Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 June 2006

An assessment of downward trends in neurodevelopmental disorders in the United States following removal of thimerosal from childhood vaccines.

David A. Geier, Mark R. Geier

Med Sci Monit 2006; 12(6): CR231-239 :: ID: 451248

Abstract

Background: The US is in the midst of an epidemic of neurodevelopmentaldisorders (NDs). Thimerosal is an ethylmercury-containing compound added to some childhood vaccines.Several previous epidemiological studies conducted in the US have associated Thimerosal-containing vaccine(TCV) administration with NDs. Material/Methods: An ecological study was undertaken to evaluate NDs reportedto the Vaccine Adverse Event Reporting System (VAERS) from 1991 through 2004 by date of receipt and bydate of vaccine administration. The NDs examined included autism, mental retardation, and speech disorders.Statistical trend analysis was employed to evaluate the effects of removal of Thimerosal on the proportionof NDs reported to VAERS. Results: There was a peak in the proportion of ND reports received by VAERSin 2001-2002 and in the proportion of ND reports by date of vaccine administration in 1998. There weresignificant reductions in the proportion of NDs reported to VAERS as Thimerosal was begun to be removedfrom childhood vaccines in the US from mid-1999 onwards. Conclusions: The present study provides thefirst epidemiological evidence showing that as Thimerosal was removed from childhood vaccines, the numberof NDs has decreased in the US. The analysis techniques utilized attempted to minimize chance or bias/confounding.Additional research should be conducted to further evaluate the relationship between TCVs and NDs. Thisis especially true because the handling of vaccine safety data from the National Immunization Programof the CDC has been called into question by the Institute of Medicine of the National Academy of Sciencesin 2005.

Keywords: Child Development Disorders, Pervasive - epidemiology, Child, Preschool, Preservatives, Pharmaceutical - toxicity, Thimerosal - toxicity, United States, Vaccines - adverse effects

Add Comment 0 Comments

Editorial

01 April 2025 : Editorial  

Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to Humans

Dinah V. Parums

DOI: 10.12659/MSM.949109

Med Sci Monit 2025; 31:e949109

0:00

In Press

Clinical Research  

Longitudinal Evaluation of Metabolic Benefits of Inactivated COVID-19 Vaccination in Diabetic Patients in T...

Med Sci Monit In Press; DOI: 10.12659/MSM.947450  

0:00

Clinical Research  

Impact of Voltage Level on Hospitalization and Mortality in Electrical Injury Cases: A Retrospective Analys...

Med Sci Monit In Press; DOI: 10.12659/MSM.947675  

Clinical Research  

Comparative Study of Plantar Load and Foot Posture Characteristics in Male Elite Squash Players and Non-Ath...

Med Sci Monit In Press; DOI: 10.12659/MSM.947828  

Clinical Research  

Dental Students’ Opinions on Use of Artificial Intelligence: A Survey Study

Med Sci Monit In Press; DOI: 10.12659/MSM.947658  

Most Viewed Current Articles

17 Jan 2024 : Review article   8,071,874

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,992

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   30,169

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   24,060

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750